Name: Bio Asia 2024
Start: 2024-02-26T10:00
End: 2024-02-28T17:00
Location: Hyderabad International Convention Centre (HICC)

Data and AI :
Redefining Possibilities

✓ Life sciences

✓ Healthtech

✓ AI-driven technologies

✓ Drug-discovery and development

Data and Artificial Intelligence (AI) have the potential to reshape the entire life sciences value chain and healthtech delivery paradigm.

BioAsia 2024 will explore the potential opportunities that data and AI can unleash for the life sciences companies, and the possibility of reshaping the future of healthtech delivery paradigm in the country. There will also be focus on data protection and cybersecurity. Read more

Where

Hyderabad International Convention Centre (HICC)

When

26th Feb - Bio-Park Visit
27th & 28th Feb - Conference

50+

Countries

70+

High Profile Speakers

800+

Corporates

1000+

Partnering Meetings

2500+

Participants

Keynote Speakers 2024

Dr. Christopher Boerner

CEO, Bristol Myers Squibb

Mr. David Ricks

CEO, Eli Lilly and Company

Mr. Geoff Martha

Chairman and CEO, Medtronic

Prof. Gregg Semenza

Nobel Laureate & Professor at
Johns Hopkins School of Medicine

Mr. Rod Hochman MD

CEO, Providence

Mr. Stefan Kaufmann

CEO, Olympus

Past Speakers

Mr. Bill Gates

Co-Chair, Bill & Melinda
Gates Foundation

Dr. Seth Berkley

CEO, Gavi Alliance

Mr. Satya N Nadella

CEo, Microsoft

Dr. Vas Narasimhan

CEO, Novartis

Mr. Alex Gorsky

Executive Chairman ,
Johnson & Johnson

Mr. Paul Polman

FORMER CEO, UNILEVER

Dr. Soumya Swaminathan

CHIEF SCIENTIST, WHO

Dr. Carl June

CAR T-CELL THERAPY
PIONEER, USA

Gallery

Schedule

1st Day

February 26, 2024

08:00 am – 04:00 pm

Biopark visits

Registrations for Bio-Park Visit are Now Closed

2nd Day

February 27, 2024

10:00 – 11:00 am

Inaugural Ceremony

11:00-11:20 am

Keynote Address by
Dr. Christopher
Boerner, CEO,

Bristol Myers Squibb

11:20-11:40 am

Keynote Address by
Prof. Gregg
Semenza, Nobel Laureate &
Professor Johns Hopkins School of Medicine - Genome Valley Award

11:40-12:00 pm

Keynote Address by
Dr. Rodney Hochman, President & CEO, Providence

12:00-13:00 pm

Panel Discussion - R&D 2.0 :
Now or never - Pushing
the boundaries to become global drug discovery engine

Speakers

Mr. GV Prasad, Managing Director & Co-Chairman, Dr Reddy's Laboratories
Dr. Sharvil Patel, Managing Director, Zydus Cadila
Mr. Toon Overstijns, Managing Director, Chairman of the Board, Miltenyi Biomedicine
Prof. Alan Rowan, Director, Australian institute for Bioengineering and Nanotechnology, University of Queensland
Prof. Rahul Purwar, Associate Professor, IIT Bombay and CEO & Founder, Immuno ACT
Dr. Sanjeev Panchal, Country President & Managing Director, AstraZeneca India

Moderator:

Dr. Ajit Shetty, Chairman VIB (Flemish Institute of Biotechnology), Former Chairman of Janssen Pharmaceuticals

13:00-14:00 pm

Networking Lunch & Visit
to Exhibition

14:00-15:15 pm

Panel Discussion -
Perception vs. Reality: Navigating India's IP Landscape in Drug Discovery

Speakers

Mr. Robert Stanley, Global Head Intellectual Property and Legal Innovation, Head Legal, International ad interim, Novartis
Mr. Sudarshan Jain, Secretary General, IPA India
Mr. Pravin Anand, Managing Partner, Anand and Anand
Mr. Samir Kazi, Executive Vice President and Head of Legal, Compliance and Intellectual Property,Glenmark Pharmaceuticals Limited
Mr. Christoph Koenen, Global Head of Clinical Development & Operations, Bayer
Ms. Leena Menghaney, IP Advisor and Head, Medicines Sans Frontiers, South Asia
Mr. Taranpreet Lamba, Vice President and Head, Portfolio Planning & IP Litigation, Sun Pharma

Moderator:

Ms Anju Ghangurde, Executive Editor (Asia Pacific), Scrip

15:15 – 16:30 pm

Panel Discussion -
Pushing Access to Medicines:
Rationalizing the Regulatory Landscape for Vaccines and Biologics

Speakers

Mr. Sai Prasad, Executive Director, Bharat Biotech International Ltd
Mr. Sanjiv Navangul, Managing Director and CEO, Bharat Serums & Vaccines
Dr. K Anand Kumar, Managing Director, Indian Immunologicals Ltd
Mr. Gary Dubin, President, Global Vaccine Business Unit, Takeda Pharmaceuticals International AG
Dr Lokesh Jain, Scientist DBT
Dr. G.V.J.A. Harshavardhan, Director General, IVMA
Mr. Harshet Jain, General Manager, Business Development, Panacea Biotec Ltd

Moderator:

Mr. Vikas Dandekar, Editor - Pharma & Life Sciences - ET Prime

16:30 – 17:30 pm

Panel Discussion -
India at the frontier of Pharma Services: Navigating the path
to global eminence in the CRO and CDMO landscape

Speakers

Mr. Jonathan Hunt, CEO & Managing Director, Syngene
Mr. Manni Kantipudi, CEO, Aragen Lifesciences
Mr. Sauri Gudlavalleti, COO, Sai Lifesciences
Mr. Akhil Ravi, Chief Executive Officer, Aurigene Pharmaceutical Services
Mr. Anil Matai, Director General, OPPI India
Mr. Giuliano Perfetti, CEO & Managing Director, Jubilant Biosys Ltd

Moderator:

Mr. Suresh Subramanian, Partner & National Life Sciences Leader, EY

17:30-18:00 pm

Networking Break & Visit
to Exhibition

18:00-19:30 pm

CEO Conclave
Geopolitical imperatives to reorganize
the global drug supply chains: How did India
fare vs. its potential and ambition?

Speakers

Mr. Satish Reddy, Chairman, Dr. Reddy’s Laboratories
Mr. Stefan Stoffel, Global Operating Partner, Advent
Dr. Satyanarayana Chava, CEO, Laurus Labs
Ms. Meenakshi Nevatia, Country President & Managing Director, Pfizer India
Ms. Nandini Piramal, Chairperson, Piramal Pharma Ltd

Moderator:

Ms. Ekta Batra, Anchor & Associate Editor
Research, CNBC-TV18

19:30 Onwards

Networking Reception

3rd Day

February 28, 2024

10:00-11:00 am

Launch of WEF C4IR
Telangana Govt. of Telangana and
Mr. Jeremy Jurgens, Managing Director WEF &
Head of the Forum's C4IR

11:00-11:20 am

Keynote Address by
Mr. David Ricks, CEO, Eli Lilly

11:20-11:40 am

Keynote Address by
Mr. Geoff Martha, Chairman & CEO, Medtronic

11:40-12:40 pm

Leading the Health-tech
revolution - The Next Normal

Speakers

Mr. Diogo Rau, EVP, Chief Information and Digital Officer, Eli Lilly and Company
Mr. Greg Meyers, EVP, Chief Digital and Technology Officer, BMS
Ms. Sangita Reddy, Joint Managing Director, Apollo Hospitals (India)
Mr. Phanimitra, Chief Digital & Information Officer, Dr Reddy’s Laboratories
Mr. Scott Burgett, Director – Health Engg. Garmin
Mr. Sriram Rajamani, Corporate Vice President & Managing Director, Microsoft Research India

Moderator:

Mr. Jeremy Jurgens, Managing Director, World Economic Forum & Head of the Forum's C4IR

12:40-13:30 pm

Unlocking the Potential
of GCCs: From Centers Of
Capability to Catalysts Of Global Transformation

Speakers

Mr. Siva Padmanabhan, MD and Head, Global Innovation and Technology Centre, AstraZeneca
Mr. Manoj Prasad, VP, GM and Head of Digital Solutions APAC, Thermo Fisher Scientific
Ms. Mrinal Duggal, Head of Sanofi Global Services, Hyderabad Hub, Sanofi
Ms. Vani Kodandaram, Head of IT Culture and Strategy, Bristol Myers Squibb
Mr. Sanjay Vyas, EVP, Global SBU Head and Managing Director India, Parexel

Moderator:

EY Partner – Sunil Venkatesh, Partner, Tech Consulting

13:30-14:30 pm

Lunch Break

14:30-15:45 pm

Panel Discussion -
MedTech is the place to be! Tech and
AI - The Powerful Combination for Medical Devices

Speakers

Chair : Dr. Arunish Chawla IAS, Secretary, Department of Pharmaceuticals, Government of India
Co-Chair : Dr. D Nageshwar Reddy, Chairman & Managing Director, AIG Hospital
Dr. Sarah McMullen, Country Director – India, FDA
Dr. Gagandeep Kang, Director-Enterics, Diagnostics, Genomics and Epidemiology, Global Health, Bill and Melinda Gates Foundation
Mr. Probir Das, Group Executive Officer, Regional Representative, Asia Pacific and India, Chairman and Managing Director, Terumo Asia Holdings Pte. Ltd, Terumo
Mr. Andre Roggan, Executive Officer & Chief Technology Officer, Olympus
Dr. Mani Prakash, VP, Enterprise R&D, Medtronic
Mr. Rajiv Nath, Forum Coordinator, Association Of Indian Medical Device Industry